These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10334556)

  • 1. Quality of life in advanced colorectal cancer.
    Conroy T; Guillemin F
    J Clin Oncol; 1999 May; 17(5):1644. PubMed ID: 10334556
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer.
    Punt CJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):88-90. PubMed ID: 11049038
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
    Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R
    Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].
    de Gramont A; Louvet C; André T; Tournigand C; Raymond E; Molitor JL; Krulik M
    Rev Med Interne; 1997; 18 Suppl 4():372s-378s. PubMed ID: 9365715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
    de Gramont A; Louvet C; Krulik M
    J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer--is there an alternative to 5-FU?
    Bleiberg H
    Eur J Cancer; 1997 Apr; 33(4):536-41. PubMed ID: 9274432
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
    Zaniboni A
    J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
    Scheithauer W; Kornek G; Marczell A; Salem G; Karner J; Kovats E; Burger D; Greiner R; Pidlich J; Schneeweiss B; Raderer M; Rosen H; Depisch D
    J Clin Oncol; 1997 Mar; 15(3):908-14. PubMed ID: 9060527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
    Grem JL
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials.
    Goldberg RM; Erlichman C
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):59-63. PubMed ID: 9726093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of meta-analyses to the evaluation of treatments for advanced colorectal cancer.
    Zelek L; Piedbois P; Buyse M
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):417-25. PubMed ID: 12647985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
    Vermeulen PB; Dirix LY; Pelgrims G; Van Oosterom AT
    Cancer; 1995 Aug; 76(3):528-30. PubMed ID: 8625138
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Fluorouracil-based treatment of patients with advanced colorectal carcinoma outside clinical trials: importance of limited toxicity.
    van Halteren HK; Keuning JJ; Vreugdenhil G
    Ann Oncol; 1997 Feb; 8(2):203. PubMed ID: 9093734
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon use in solid tumors.
    John WJ; Foon KA
    Cancer Treat Res; 1998; 94():23-33. PubMed ID: 9587680
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
    Loeffler TM; Hausamen TU
    J Infus Chemother; 1996; 6(3):137-40. PubMed ID: 9229325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase inhibition, a dead end?
    Herrmann R
    Eur J Cancer; 1995 Nov; 31A(12):1919-20. PubMed ID: 8562141
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies.
    Labianca R; Pessi A; Facendola G; Pirovano M; Luporini G
    Eur J Cancer; 1996; 32A Suppl 5():S7-12. PubMed ID: 8958036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer.
    Reina JJ; Aparicio J; Salvador J; Pica JM; Rueda A; Lorenzo A; de la Puente CG; Borrega P; Moreno-Nogueira JA
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):339-45. PubMed ID: 12851783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
    Rubiales AS; del Valle ML
    Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
    [No Abstract]   [Full Text] [Related]  

  • 20. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
    Gambill BD
    Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.